In an interview with the Cancer History Project, Kay Dickersin, one of the early leaders of the grassroots breast cancer patient advocacy movement, recounted the beginnings of the National Breast Cancer Coalition.
The year of 2022 was probably the most challenging and hard for Ukraine since the start of our independence. Our lives have changed significantly as we are fighting for the world’s freedom and democracy. In these circumstances, the Ukrainian healthcare system remained stable and doctors kept doing their job at hospitals around the country, including oncologists who did their best to treat patients in any way possible.
In 1971, when the National Cancer Act was signed, J. Palmer Saunders was the director of the Division of Cancer Research, Resources and Centers.
S2302 Pragmatica-Lung is a federally-funded, streamlined clinical trial examining a new combination of agents in patients with advanced non-small cell lung cancer (NSCLC). Like most studies, it is focused on improving outcomes for patients with cancer—but it is also poised to simplify and transform the entire clinical trials model as we know it.
Steady advancements in cancer treatments over the past century have led to significant improvements in the expected lifespan of cancer patients. However, to this day, cancer is very rarely cured.
2022 was the year to try to return to normal—or at least an approximation thereof.
The Cancer History Project preserves legacies, stories, and transcripts.
Monica Bertagnolli, the 16th director of the National Cancer Institute, announced that she will be undergoing treatment for early-stage breast cancer.
Rutgers Cancer Institute of New Jersey opened its doors in 1993 as the result of a P20 planning grant, and in 1997 became the first NCI-designated cancer center in New Jersey.
Dr. Jo Anne L. Earp, 79, professor emerita and past chair in the Department of Health Behavior at the UNC Gillings School of Global Public Health, passed away in the early hours of Nov. 18 at UNC Hospitals in Chapel Hill, NC.
